Sleep apnea plus dim light at night increases depression, anxiety in mice

(Medical Xpress)—New research suggests the estimated 12 million Americans who have obstructive sleep apnea should take better care to sleep in a very dark room. Scientists at The Ohio State University Wexner Medical Center have found exposure to dim light at night can interact with sleep apnea and lead to increased levels of depression and anxiety in mice.

"Although it is unclear at the present time whether sleep apnea causes depression, both conditions are commonly seen together in patients. Our research suggests that sleeping even with a minimum amount of light may increase in those with sleep apnea," said Dr. Ulysses Magalang, director of Ohio State's Sleep Disorders Center and a co-author of the study.

Results of the research were recently published online by the American Journal of Physiology – Regulatory Integrative and Comparative Physiology.

The study involved mice that were placed in sleep apnea-like conditions that mimic the repetitive lowering of that sleep apnea patients experience. Half were kept in normal during the day and total darkness at night. The other half was exposed to dim light at night using a 40-watt light bulb in the lab. The group in dim light had higher anxiety behaviors and more depressive behaviors than the mice kept in the dark environment. Scientists also observed impaired among both sets of mice.

This video is not supported by your browser at this time.

"Not only were these changes observed during field and maze tests, but we also recorded physical changes, including a reduction of cell size in the hippocampus, an area of the brain important in memory and ," said Taryn Aubrecht, first author of the study and a neuroscience graduate student at Ohio State. "The combination of dim light exposure and sleep apnea appears to result in increased depressive and anxiety-like behaviors in mice, so limiting exposure to light at night could be a very simple strategy to help patients with sleep apnea," Magalang said. "We're currently exploring further human testing."

Obstructive sleep apnea is a common problem, especially among smokers and people who are overweight. The disorder is linked to high blood pressure, diabetes and higher risk of stroke and heart failure. The most common signs include loud snoring, daytime sleepiness, irritability and memory problems. Magalang offers these suggestions for improving sleep and reducing dim light exposure at night:

  • Use room-darkening drapes or shades on windows to block outside light from traffic, streetlights and neighboring buildings.
  • Turn off the television, computer or other electronic devices before going to sleep.
  • Choose clocks or night lights with red lighting instead of blue or green.

add to favorites email to friend print save as pdf

Related Stories

Race apparently a factor in sleep apnea

Jun 26, 2013

A Wayne State University researcher has found that sleep apnea severity is higher among African-American men in certain age ranges, even after controlling for body mass index (BMI).

Sleep apnea increases risk of sudden cardiac death

Jun 11, 2013

A moderate case of obstructive sleep apnea can significantly increase a person's risk for sudden cardiac death, an often fatal condition where the heart stops beating and must be immediately treated with ...

Recommended for you

Sleep-disordered breathing linked to functional decline

Dec 06, 2014

(HealthDay)—For older women, sleep-disordered breathing (SDB) is associated with functional decline, according to a study published in the November issue of the Journal of the American Geriatrics Society.

Sleep apnea linked to poor aerobic fitness

Nov 24, 2014

People with moderate to severe obstructive sleep apnea may have an intrinsic inability to burn high amounts of oxygen during strenuous aerobic exercise, according to a new study led by researchers at University ...

Sleep apnea may contribute to kidney disease progression

Nov 14, 2014

Sleep apnea may accelerate kidney function decline in diabetic patients with kidney disease, according to a study that will be presented at ASN Kidney Week 2014 November 11-16 at the Pennsylvania Convention Center in Philadelphia, ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.